Jeanelle Sheeder
Concepts (626)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Contraception | 19 | 2024 | 142 | 7.230 |
Why?
| Contraceptive Agents, Female | 26 | 2024 | 76 | 4.510 |
Why?
| Family Planning Services | 12 | 2023 | 81 | 3.500 |
Why?
| Contraception Behavior | 19 | 2024 | 91 | 3.440 |
Why?
| Desogestrel | 22 | 2024 | 46 | 3.290 |
Why?
| Contraceptive Agents | 7 | 2023 | 60 | 3.280 |
Why?
| Pregnancy in Adolescence | 18 | 2024 | 78 | 3.170 |
Why?
| Long-Acting Reversible Contraception | 9 | 2024 | 32 | 2.440 |
Why?
| Pregnancy | 76 | 2024 | 6247 | 2.260 |
Why?
| Abortion, Induced | 13 | 2024 | 95 | 2.120 |
Why?
| Drug Implants | 20 | 2024 | 82 | 2.020 |
Why?
| Prenatal Care | 9 | 2020 | 272 | 1.960 |
Why?
| Hospitals, Religious | 5 | 2020 | 5 | 1.710 |
Why?
| Adolescent Health Services | 4 | 2024 | 76 | 1.640 |
Why?
| Counseling | 6 | 2020 | 382 | 1.570 |
Why?
| Intrauterine Devices | 7 | 2019 | 26 | 1.550 |
Why?
| Postpartum Period | 11 | 2024 | 332 | 1.550 |
Why?
| Female | 168 | 2024 | 68162 | 1.530 |
Why?
| Adolescent | 90 | 2024 | 20197 | 1.520 |
Why?
| Gynecology | 10 | 2023 | 174 | 1.460 |
Why?
| Young Adult | 67 | 2024 | 12286 | 1.430 |
Why?
| Adolescent Behavior | 9 | 2015 | 498 | 1.420 |
Why?
| Pregnancy Outcome | 8 | 2021 | 379 | 1.190 |
Why?
| Reproductive Health | 4 | 2023 | 79 | 1.170 |
Why?
| Endometrial Neoplasms | 10 | 2022 | 163 | 1.160 |
Why?
| Humans | 185 | 2024 | 128896 | 1.140 |
Why?
| Catholicism | 5 | 2020 | 9 | 1.130 |
Why?
| Chlamydia Infections | 3 | 2024 | 71 | 1.120 |
Why?
| Colorado | 35 | 2024 | 4443 | 1.060 |
Why?
| Health Knowledge, Attitudes, Practice | 11 | 2024 | 1264 | 1.030 |
Why?
| Obstetrics | 7 | 2023 | 159 | 1.010 |
Why?
| Contraceptives, Oral, Combined | 2 | 2023 | 17 | 0.980 |
Why?
| Postnatal Care | 3 | 2021 | 71 | 0.920 |
Why?
| Patient Acceptance of Health Care | 3 | 2020 | 764 | 0.920 |
Why?
| Adult | 89 | 2024 | 35361 | 0.910 |
Why?
| Trichomonas Infections | 1 | 2024 | 11 | 0.890 |
Why?
| Trichomonas vaginalis | 1 | 2024 | 13 | 0.890 |
Why?
| Confidentiality | 1 | 2024 | 70 | 0.870 |
Why?
| Sexual Behavior | 7 | 2022 | 453 | 0.860 |
Why?
| Enoxaparin | 2 | 2020 | 59 | 0.830 |
Why?
| Patient Satisfaction | 5 | 2023 | 639 | 0.830 |
Why?
| Cross-Sectional Studies | 24 | 2024 | 5032 | 0.810 |
Why?
| Religion and Medicine | 3 | 2020 | 26 | 0.780 |
Why?
| Pyridones | 2 | 2020 | 158 | 0.780 |
Why?
| Sexually Transmitted Diseases | 1 | 2024 | 146 | 0.770 |
Why?
| Surveys and Questionnaires | 25 | 2024 | 5355 | 0.760 |
Why?
| Levonorgestrel | 4 | 2018 | 34 | 0.710 |
Why?
| Ambulatory Care Facilities | 5 | 2024 | 226 | 0.710 |
Why?
| Pregnant Women | 2 | 2019 | 126 | 0.700 |
Why?
| Pyrazoles | 2 | 2020 | 403 | 0.680 |
Why?
| Group Processes | 2 | 2018 | 55 | 0.680 |
Why?
| Parity | 5 | 2016 | 120 | 0.680 |
Why?
| Mothers | 5 | 2022 | 723 | 0.670 |
Why?
| Religion and Psychology | 1 | 2019 | 27 | 0.660 |
Why?
| Hysterectomy | 6 | 2019 | 118 | 0.660 |
Why?
| Venous Thromboembolism | 2 | 2020 | 271 | 0.660 |
Why?
| Postoperative Hemorrhage | 1 | 2020 | 85 | 0.660 |
Why?
| Intention | 5 | 2024 | 158 | 0.640 |
Why?
| Pregnancy Rate | 2 | 2017 | 60 | 0.640 |
Why?
| Sex Offenses | 1 | 2022 | 172 | 0.630 |
Why?
| Patient-Centered Care | 2 | 2021 | 504 | 0.630 |
Why?
| Ovarian Neoplasms | 6 | 2020 | 474 | 0.630 |
Why?
| Community Health Services | 2 | 2023 | 224 | 0.630 |
Why?
| Rural Health Services | 1 | 2019 | 109 | 0.620 |
Why?
| Vulnerable Populations | 1 | 2020 | 155 | 0.610 |
Why?
| Financial Support | 1 | 2018 | 19 | 0.610 |
Why?
| Health Care Sector | 1 | 2018 | 25 | 0.600 |
Why?
| Intrauterine Devices, Copper | 5 | 2018 | 7 | 0.600 |
Why?
| Pregnancy, Unplanned | 3 | 2017 | 37 | 0.590 |
Why?
| Fibrinolytic Agents | 1 | 2020 | 264 | 0.580 |
Why?
| Prosthesis Implantation | 2 | 2017 | 149 | 0.570 |
Why?
| Health Services Accessibility | 4 | 2024 | 894 | 0.560 |
Why?
| Luteal Phase | 1 | 2017 | 44 | 0.540 |
Why?
| Infant, Low Birth Weight | 2 | 2015 | 134 | 0.540 |
Why?
| Intrauterine Devices, Medicated | 6 | 2017 | 26 | 0.540 |
Why?
| Chlamydia trachomatis | 3 | 2024 | 44 | 0.530 |
Why?
| Delivery of Health Care | 2 | 2023 | 896 | 0.530 |
Why?
| Retrospective Studies | 33 | 2024 | 14546 | 0.530 |
Why?
| Lacerations | 3 | 2022 | 29 | 0.510 |
Why?
| Parenting | 1 | 2020 | 291 | 0.510 |
Why?
| Interprofessional Relations | 1 | 2018 | 272 | 0.500 |
Why?
| Life Style | 4 | 2024 | 459 | 0.500 |
Why?
| Group Structure | 1 | 2015 | 1 | 0.490 |
Why?
| Depression, Postpartum | 3 | 2020 | 129 | 0.490 |
Why?
| Guatemala | 3 | 2021 | 310 | 0.480 |
Why?
| Genital Neoplasms, Female | 4 | 2020 | 80 | 0.480 |
Why?
| Perimenopause | 1 | 2015 | 63 | 0.480 |
Why?
| Risk | 2 | 2017 | 866 | 0.480 |
Why?
| Carcinoma, Endometrioid | 3 | 2022 | 46 | 0.480 |
Why?
| Health Personnel | 1 | 2021 | 642 | 0.480 |
Why?
| Fertility Preservation | 3 | 2023 | 54 | 0.460 |
Why?
| Uterus | 1 | 2015 | 204 | 0.460 |
Why?
| Multicenter Studies as Topic | 1 | 2015 | 287 | 0.460 |
Why?
| Randomized Controlled Trials as Topic | 3 | 2019 | 1366 | 0.450 |
Why?
| Patient Selection | 3 | 2015 | 671 | 0.450 |
Why?
| Safety-net Providers | 1 | 2015 | 108 | 0.440 |
Why?
| Maternal Age | 3 | 2018 | 121 | 0.430 |
Why?
| Goals | 1 | 2014 | 161 | 0.410 |
Why?
| Mass Screening | 9 | 2023 | 1121 | 0.410 |
Why?
| Primary Health Care | 4 | 2023 | 1661 | 0.410 |
Why?
| Attitude to Health | 3 | 2020 | 424 | 0.410 |
Why?
| Middle Aged | 39 | 2022 | 30977 | 0.400 |
Why?
| Choice Behavior | 3 | 2019 | 158 | 0.400 |
Why?
| Papillomavirus Vaccines | 1 | 2015 | 229 | 0.400 |
Why?
| Uterine Cervical Neoplasms | 3 | 2021 | 233 | 0.390 |
Why?
| Internship and Residency | 6 | 2023 | 1052 | 0.390 |
Why?
| Estradiol | 1 | 2015 | 494 | 0.390 |
Why?
| Premature Birth | 1 | 2015 | 313 | 0.380 |
Why?
| Gestational Age | 5 | 2024 | 857 | 0.370 |
Why?
| Postoperative Complications | 9 | 2020 | 2494 | 0.370 |
Why?
| Obstetric Labor Complications | 2 | 2022 | 30 | 0.360 |
Why?
| Child | 19 | 2024 | 20824 | 0.360 |
Why?
| Magnetoencephalography | 13 | 2000 | 119 | 0.350 |
Why?
| Feasibility Studies | 7 | 2022 | 859 | 0.340 |
Why?
| Disclosure | 2 | 2022 | 109 | 0.340 |
Why?
| Attitude of Health Personnel | 3 | 2024 | 1090 | 0.330 |
Why?
| United States | 19 | 2021 | 13975 | 0.330 |
Why?
| Robotic Surgical Procedures | 3 | 2016 | 108 | 0.330 |
Why?
| Functional Laterality | 11 | 2001 | 216 | 0.330 |
Why?
| Health Behavior | 1 | 2015 | 732 | 0.330 |
Why?
| Socioeconomic Factors | 5 | 2021 | 1192 | 0.330 |
Why?
| Nurse Midwives | 2 | 2020 | 33 | 0.330 |
Why?
| Lymph Nodes | 3 | 2018 | 458 | 0.330 |
Why?
| Condoms | 3 | 2017 | 102 | 0.320 |
Why?
| Birth Intervals | 2 | 2019 | 20 | 0.320 |
Why?
| Evoked Potentials, Auditory | 10 | 2001 | 176 | 0.320 |
Why?
| Communication | 3 | 2022 | 839 | 0.310 |
Why?
| Male | 45 | 2024 | 63146 | 0.310 |
Why?
| Intrauterine Device Expulsion | 3 | 2017 | 9 | 0.300 |
Why?
| Infant, Small for Gestational Age | 2 | 2019 | 83 | 0.300 |
Why?
| Time Factors | 12 | 2024 | 6568 | 0.290 |
Why?
| Patient Participation | 1 | 2012 | 402 | 0.290 |
Why?
| Quality Improvement | 4 | 2024 | 1101 | 0.280 |
Why?
| Sexual Partners | 3 | 2024 | 179 | 0.280 |
Why?
| Attitude | 3 | 2019 | 247 | 0.280 |
Why?
| Cohort Studies | 11 | 2021 | 5394 | 0.280 |
Why?
| Prediabetic State | 2 | 2023 | 242 | 0.280 |
Why?
| Pregnancy Complications | 4 | 2019 | 487 | 0.280 |
Why?
| Women's Health | 2 | 2020 | 361 | 0.280 |
Why?
| Vaccination | 1 | 2015 | 1350 | 0.270 |
Why?
| Uterine Cervicitis | 1 | 2006 | 7 | 0.270 |
Why?
| Organizational Policy | 2 | 2019 | 76 | 0.270 |
Why?
| Age Factors | 8 | 2016 | 3133 | 0.250 |
Why?
| Perineum | 3 | 2022 | 26 | 0.250 |
Why?
| Marijuana Use | 2 | 2019 | 192 | 0.250 |
Why?
| Prospective Studies | 14 | 2022 | 7060 | 0.250 |
Why?
| Aged, 80 and over | 11 | 2021 | 7050 | 0.250 |
Why?
| Depression | 4 | 2023 | 1289 | 0.240 |
Why?
| Gelatin | 2 | 2016 | 40 | 0.240 |
Why?
| Pregnancy Trimester, First | 4 | 2023 | 133 | 0.240 |
Why?
| Diabetes Mellitus, Type 2 | 4 | 2023 | 2421 | 0.240 |
Why?
| Aged | 18 | 2021 | 22035 | 0.240 |
Why?
| Clinical Competence | 3 | 2018 | 1020 | 0.240 |
Why?
| Electronics, Medical | 1 | 2004 | 7 | 0.240 |
Why?
| Fetal Death | 2 | 2016 | 55 | 0.240 |
Why?
| Laparotomy | 2 | 2015 | 108 | 0.240 |
Why?
| Weight Gain | 6 | 2021 | 504 | 0.230 |
Why?
| Legal Guardians | 1 | 2024 | 9 | 0.230 |
Why?
| Database Management Systems | 1 | 2004 | 47 | 0.230 |
Why?
| Thrombin | 2 | 2016 | 146 | 0.230 |
Why?
| Privacy | 1 | 2024 | 33 | 0.230 |
Why?
| Contact Tracing | 1 | 2024 | 20 | 0.220 |
Why?
| Telemedicine | 2 | 2023 | 773 | 0.220 |
Why?
| Pregnancy Trimester, Second | 4 | 2018 | 73 | 0.220 |
Why?
| Aromatherapy | 1 | 2023 | 2 | 0.220 |
Why?
| Scapula | 1 | 2024 | 45 | 0.220 |
Why?
| Contraceptive Devices | 1 | 2023 | 1 | 0.220 |
Why?
| Pain, Procedural | 1 | 2023 | 14 | 0.220 |
Why?
| Fellowships and Scholarships | 2 | 2018 | 271 | 0.220 |
Why?
| Ethinyl Estradiol | 1 | 2023 | 17 | 0.220 |
Why?
| Social Support | 2 | 2020 | 581 | 0.220 |
Why?
| Birth Weight | 1 | 2006 | 493 | 0.210 |
Why?
| House Calls | 2 | 2019 | 123 | 0.210 |
Why?
| Decision Making | 4 | 2016 | 837 | 0.210 |
Why?
| Patient Health Questionnaire | 1 | 2023 | 34 | 0.210 |
Why?
| Cost-Benefit Analysis | 3 | 2020 | 615 | 0.210 |
Why?
| Pediatricians | 1 | 2024 | 133 | 0.210 |
Why?
| Fertility | 3 | 2023 | 161 | 0.210 |
Why?
| Pediatrics | 2 | 2024 | 1060 | 0.210 |
Why?
| Device Removal | 1 | 2024 | 140 | 0.210 |
Why?
| Physician's Role | 1 | 2024 | 202 | 0.210 |
Why?
| Abortion, Spontaneous | 1 | 2023 | 97 | 0.200 |
Why?
| Leuprolide | 1 | 2022 | 19 | 0.200 |
Why?
| Semen | 1 | 2022 | 19 | 0.200 |
Why?
| Pain | 2 | 2018 | 761 | 0.200 |
Why?
| Patient Preference | 2 | 2015 | 182 | 0.200 |
Why?
| Exercise | 3 | 2024 | 1923 | 0.200 |
Why?
| Pregnancy Tests | 2 | 2017 | 8 | 0.200 |
Why?
| Fetal Membranes, Premature Rupture | 1 | 2021 | 35 | 0.190 |
Why?
| Students, Medical | 2 | 2016 | 305 | 0.190 |
Why?
| Pilot Projects | 4 | 2024 | 1545 | 0.190 |
Why?
| Treatment Adherence and Compliance | 1 | 2021 | 22 | 0.190 |
Why?
| Chorioamnionitis | 1 | 2021 | 38 | 0.190 |
Why?
| Decision Support Techniques | 2 | 2020 | 387 | 0.180 |
Why?
| beta Catenin | 2 | 2022 | 220 | 0.180 |
Why?
| Maternal-Child Health Services | 1 | 2020 | 12 | 0.180 |
Why?
| Self Report | 3 | 2021 | 796 | 0.180 |
Why?
| Lymph Node Excision | 3 | 2018 | 166 | 0.170 |
Why?
| Parturition | 2 | 2019 | 66 | 0.170 |
Why?
| Evoked Potentials, Somatosensory | 2 | 1999 | 32 | 0.170 |
Why?
| Patient Education as Topic | 3 | 2019 | 734 | 0.170 |
Why?
| Magnetics | 2 | 1999 | 44 | 0.170 |
Why?
| Accelerometry | 1 | 2021 | 89 | 0.170 |
Why?
| Quality-Adjusted Life Years | 1 | 2020 | 116 | 0.170 |
Why?
| Outpatients | 3 | 2023 | 366 | 0.170 |
Why?
| Uterine Hemorrhage | 2 | 2021 | 34 | 0.170 |
Why?
| Home Health Nursing | 1 | 2019 | 10 | 0.170 |
Why?
| Health Facilities | 1 | 2020 | 80 | 0.170 |
Why?
| Menstruation Disturbances | 1 | 2019 | 12 | 0.170 |
Why?
| Body Mass Index | 5 | 2024 | 2244 | 0.170 |
Why?
| Pharmacogenetics | 1 | 2021 | 170 | 0.160 |
Why?
| Ambulatory Surgical Procedures | 2 | 2017 | 52 | 0.160 |
Why?
| Hysterectomy, Vaginal | 1 | 2019 | 3 | 0.160 |
Why?
| Factor Analysis, Statistical | 1 | 2020 | 284 | 0.160 |
Why?
| Dietary Supplements | 1 | 2023 | 533 | 0.160 |
Why?
| Candidiasis, Vulvovaginal | 1 | 2019 | 4 | 0.160 |
Why?
| Cytochrome P450 Family 3 | 1 | 2019 | 3 | 0.160 |
Why?
| Transgender Persons | 1 | 2022 | 174 | 0.160 |
Why?
| Insulin Resistance | 2 | 2008 | 1163 | 0.160 |
Why?
| Medical Oncology | 2 | 2019 | 273 | 0.160 |
Why?
| Neoplasm Staging | 6 | 2020 | 1285 | 0.160 |
Why?
| Vaginosis, Bacterial | 1 | 2019 | 13 | 0.160 |
Why?
| Cues | 1 | 2022 | 319 | 0.160 |
Why?
| Double-Blind Method | 5 | 2018 | 1858 | 0.160 |
Why?
| Obesity | 5 | 2016 | 2844 | 0.160 |
Why?
| Clothing | 1 | 2019 | 20 | 0.160 |
Why?
| Hygiene | 1 | 2019 | 30 | 0.160 |
Why?
| Cancer Pain | 1 | 2019 | 26 | 0.160 |
Why?
| Live Birth | 1 | 2019 | 55 | 0.160 |
Why?
| Anesthesia, Inhalation | 1 | 2018 | 6 | 0.160 |
Why?
| Anesthesia, Intravenous | 1 | 2018 | 11 | 0.160 |
Why?
| Anesthetics, Inhalation | 1 | 2018 | 16 | 0.160 |
Why?
| Treatment Outcome | 10 | 2020 | 10239 | 0.160 |
Why?
| Nitrous Oxide | 1 | 2018 | 22 | 0.150 |
Why?
| Databases, Factual | 3 | 2021 | 1289 | 0.150 |
Why?
| Anesthetics, Intravenous | 1 | 2018 | 39 | 0.150 |
Why?
| Physician Assistants | 1 | 2020 | 87 | 0.150 |
Why?
| Models, Anatomic | 1 | 2019 | 94 | 0.150 |
Why?
| Genitalia, Female | 1 | 2018 | 38 | 0.150 |
Why?
| Databases as Topic | 2 | 2008 | 65 | 0.150 |
Why?
| Hemostasis, Surgical | 2 | 2016 | 19 | 0.150 |
Why?
| Progesterone | 1 | 2019 | 244 | 0.150 |
Why?
| Nurse Practitioners | 1 | 2020 | 126 | 0.150 |
Why?
| Ovariectomy | 2 | 2015 | 135 | 0.150 |
Why?
| Organ Transplantation | 1 | 2021 | 225 | 0.150 |
Why?
| Off-Label Use | 1 | 2018 | 51 | 0.150 |
Why?
| Oncologists | 1 | 2018 | 36 | 0.150 |
Why?
| Culture | 1 | 2019 | 125 | 0.150 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2015 | 1570 | 0.150 |
Why?
| Logistic Models | 6 | 2024 | 1963 | 0.150 |
Why?
| Adenocarcinoma | 2 | 2015 | 895 | 0.150 |
Why?
| Risk-Taking | 2 | 2019 | 344 | 0.140 |
Why?
| Psychometrics | 4 | 2009 | 681 | 0.140 |
Why?
| Commerce | 1 | 2018 | 68 | 0.140 |
Why?
| Patient Protection and Affordable Care Act | 1 | 2018 | 101 | 0.140 |
Why?
| Sterilization, Reproductive | 1 | 2017 | 7 | 0.140 |
Why?
| Quality of Health Care | 2 | 2021 | 610 | 0.140 |
Why?
| Hysteroscopy | 1 | 2017 | 10 | 0.140 |
Why?
| Demyelinating Diseases | 1 | 1998 | 82 | 0.140 |
Why?
| Urinary Tract Infections | 1 | 2019 | 144 | 0.140 |
Why?
| Delivery, Obstetric | 4 | 2022 | 133 | 0.140 |
Why?
| Adenocarcinoma, Mucinous | 1 | 2018 | 72 | 0.140 |
Why?
| Professional-Patient Relations | 1 | 2018 | 142 | 0.140 |
Why?
| Infant, Newborn | 6 | 2021 | 5704 | 0.140 |
Why?
| Salpingectomy | 2 | 2015 | 13 | 0.140 |
Why?
| Sexual Dysfunctions, Psychological | 1 | 2017 | 34 | 0.140 |
Why?
| Bipolar Disorder | 1 | 1999 | 232 | 0.140 |
Why?
| Family | 1 | 2021 | 650 | 0.130 |
Why?
| Incidence | 5 | 2019 | 2634 | 0.130 |
Why?
| Surgeons | 2 | 2018 | 279 | 0.130 |
Why?
| Brain Diseases | 1 | 1998 | 132 | 0.130 |
Why?
| Ultrasonography | 2 | 2019 | 727 | 0.130 |
Why?
| Abortion, Therapeutic | 1 | 2016 | 4 | 0.130 |
Why?
| Dilatation and Curettage | 1 | 2016 | 12 | 0.130 |
Why?
| Polymorphism, Genetic | 1 | 2019 | 641 | 0.130 |
Why?
| Conflict of Interest | 1 | 2018 | 124 | 0.130 |
Why?
| Pelvic Infection | 1 | 2016 | 4 | 0.130 |
Why?
| Minority Groups | 1 | 2018 | 240 | 0.130 |
Why?
| Ambulatory Care | 1 | 2020 | 509 | 0.130 |
Why?
| Sexual Dysfunction, Physiological | 1 | 2017 | 67 | 0.130 |
Why?
| Follow-Up Studies | 8 | 2019 | 4917 | 0.130 |
Why?
| Medical Marijuana | 1 | 2018 | 108 | 0.130 |
Why?
| Tissue Adhesives | 1 | 2016 | 18 | 0.130 |
Why?
| Weight Reduction Programs | 1 | 2017 | 107 | 0.130 |
Why?
| Magnetic Resonance Imaging | 7 | 2001 | 3348 | 0.130 |
Why?
| Infant | 3 | 2023 | 8994 | 0.130 |
Why?
| Contraception, Postcoital | 1 | 2016 | 6 | 0.130 |
Why?
| Internet | 2 | 2019 | 616 | 0.130 |
Why?
| Cerebral Cortex | 1 | 1999 | 407 | 0.130 |
Why?
| Surgical Wound Infection | 1 | 2019 | 291 | 0.130 |
Why?
| Medroxyprogesterone Acetate | 1 | 2015 | 35 | 0.130 |
Why?
| Pregnancy, Unwanted | 1 | 2015 | 13 | 0.130 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 1998 | 510 | 0.130 |
Why?
| Patient Compliance | 2 | 2012 | 563 | 0.120 |
Why?
| Risk Reduction Behavior | 2 | 2014 | 212 | 0.120 |
Why?
| Anticoagulants | 1 | 2020 | 622 | 0.120 |
Why?
| Administration, Cutaneous | 1 | 2015 | 130 | 0.120 |
Why?
| Placebos | 1 | 2015 | 203 | 0.120 |
Why?
| Healthcare Disparities | 1 | 2021 | 570 | 0.120 |
Why?
| Interpersonal Relations | 2 | 2017 | 387 | 0.120 |
Why?
| Hot Flashes | 1 | 2015 | 81 | 0.120 |
Why?
| Curriculum | 3 | 2018 | 925 | 0.120 |
Why?
| Advanced Practice Nursing | 1 | 2015 | 28 | 0.120 |
Why?
| Radiography, Thoracic | 1 | 2016 | 162 | 0.120 |
Why?
| Contraceptives, Oral | 1 | 2015 | 38 | 0.120 |
Why?
| Papillomaviridae | 1 | 2015 | 112 | 0.120 |
Why?
| Physician-Patient Relations | 2 | 2019 | 537 | 0.120 |
Why?
| Risk Factors | 10 | 2022 | 9792 | 0.120 |
Why?
| Antineoplastic Agents, Hormonal | 1 | 2015 | 157 | 0.120 |
Why?
| Abdominal Abscess | 1 | 2014 | 26 | 0.120 |
Why?
| Pandemics | 1 | 2023 | 1516 | 0.120 |
Why?
| Delayed-Action Preparations | 1 | 2015 | 178 | 0.110 |
Why?
| Immunization Schedule | 1 | 2015 | 197 | 0.110 |
Why?
| Neoplasm Grading | 3 | 2022 | 277 | 0.110 |
Why?
| Genetic Variation | 1 | 2019 | 935 | 0.110 |
Why?
| Endometrium | 1 | 2014 | 61 | 0.110 |
Why?
| Glycoproteins | 1 | 2015 | 340 | 0.110 |
Why?
| Schizophrenia | 4 | 2000 | 433 | 0.110 |
Why?
| Digoxin | 1 | 2013 | 30 | 0.110 |
Why?
| Fatigue | 1 | 2015 | 319 | 0.110 |
Why?
| Otolaryngology | 1 | 2015 | 84 | 0.110 |
Why?
| Pelvic Neoplasms | 1 | 2013 | 19 | 0.110 |
Why?
| Antigens, CD | 1 | 2015 | 479 | 0.110 |
Why?
| Fallopian Tube Neoplasms | 1 | 2013 | 15 | 0.110 |
Why?
| Brain | 8 | 2001 | 2592 | 0.110 |
Why?
| Neoplasm Recurrence, Local | 1 | 2019 | 952 | 0.100 |
Why?
| Robotics | 1 | 2014 | 88 | 0.100 |
Why?
| Umbilical Cord | 1 | 2013 | 84 | 0.100 |
Why?
| Peer Group | 1 | 2015 | 224 | 0.100 |
Why?
| Motivational Interviewing | 1 | 2014 | 99 | 0.100 |
Why?
| Overweight | 1 | 2017 | 522 | 0.100 |
Why?
| Travel | 2 | 2024 | 123 | 0.100 |
Why?
| Cystadenocarcinoma, Serous | 1 | 2013 | 66 | 0.100 |
Why?
| Hemorrhage | 1 | 2016 | 658 | 0.100 |
Why?
| Papillomavirus Infections | 1 | 2015 | 290 | 0.100 |
Why?
| Neoplastic Stem Cells | 1 | 2015 | 376 | 0.090 |
Why?
| Rural Population | 3 | 2022 | 504 | 0.090 |
Why?
| Practice Patterns, Physicians' | 1 | 2020 | 1281 | 0.090 |
Why?
| Opioid-Related Disorders | 1 | 2019 | 502 | 0.090 |
Why?
| Guideline Adherence | 2 | 2021 | 526 | 0.090 |
Why?
| Analgesics, Opioid | 1 | 2019 | 914 | 0.090 |
Why?
| School Health Services | 1 | 2014 | 233 | 0.090 |
Why?
| Abortion Applicants | 1 | 2010 | 2 | 0.090 |
Why?
| Education, Medical, Graduate | 1 | 2015 | 436 | 0.090 |
Why?
| Glucose Tolerance Test | 2 | 2013 | 356 | 0.090 |
Why?
| Odds Ratio | 2 | 2016 | 1019 | 0.090 |
Why?
| Blood Loss, Surgical | 3 | 2016 | 91 | 0.090 |
Why?
| Health Care Costs | 1 | 2014 | 404 | 0.090 |
Why?
| Anal Canal | 2 | 2022 | 89 | 0.090 |
Why?
| Domestic Violence | 1 | 2010 | 49 | 0.090 |
Why?
| Clinical Clerkship | 1 | 2011 | 89 | 0.090 |
Why?
| Medication Adherence | 1 | 2015 | 571 | 0.090 |
Why?
| Peptides | 1 | 2015 | 902 | 0.090 |
Why?
| Pediatric Obesity | 1 | 2017 | 568 | 0.090 |
Why?
| Sleep | 1 | 2015 | 657 | 0.080 |
Why?
| Neoplasm Invasiveness | 3 | 2017 | 479 | 0.080 |
Why?
| Preoperative Care | 3 | 2017 | 343 | 0.080 |
Why?
| Linear Models | 3 | 2019 | 817 | 0.080 |
Why?
| Risk Assessment | 4 | 2016 | 3286 | 0.080 |
Why?
| Latin America | 1 | 2009 | 83 | 0.080 |
Why?
| Misoprostol | 1 | 2009 | 17 | 0.080 |
Why?
| Abortifacient Agents, Nonsteroidal | 1 | 2009 | 21 | 0.080 |
Why?
| Gynecologic Surgical Procedures | 2 | 2020 | 54 | 0.080 |
Why?
| Referral and Consultation | 2 | 2018 | 727 | 0.080 |
Why?
| Research Design | 1 | 2015 | 1038 | 0.080 |
Why?
| Personality Inventory | 1 | 2009 | 138 | 0.080 |
Why?
| Interferon-beta | 2 | 2000 | 88 | 0.080 |
Why?
| Case-Control Studies | 5 | 2020 | 3334 | 0.080 |
Why?
| Medical Records Systems, Computerized | 1 | 2009 | 91 | 0.080 |
Why?
| Dominance, Cerebral | 2 | 2000 | 53 | 0.080 |
Why?
| Weight Loss | 2 | 2017 | 723 | 0.080 |
Why?
| Sex Factors | 6 | 2020 | 1947 | 0.070 |
Why?
| Nausea | 2 | 2019 | 104 | 0.070 |
Why?
| Temporal Lobe | 3 | 1997 | 83 | 0.070 |
Why?
| Menarche | 1 | 2008 | 58 | 0.070 |
Why?
| Models, Theoretical | 1 | 2012 | 550 | 0.070 |
Why?
| Breast Feeding | 1 | 2012 | 423 | 0.070 |
Why?
| Psychotic Disorders | 2 | 2000 | 152 | 0.070 |
Why?
| Smoking | 1 | 2015 | 1501 | 0.070 |
Why?
| Schizophrenia, Paranoid | 2 | 1997 | 9 | 0.070 |
Why?
| Comorbidity | 2 | 2016 | 1542 | 0.070 |
Why?
| Societies, Medical | 3 | 2018 | 760 | 0.070 |
Why?
| Reference Values | 3 | 2018 | 791 | 0.070 |
Why?
| Students, Health Occupations | 1 | 2007 | 28 | 0.070 |
Why?
| Healthy Volunteers | 2 | 2019 | 204 | 0.070 |
Why?
| Clinical Laboratory Techniques | 1 | 2007 | 86 | 0.070 |
Why?
| Tumor Suppressor Protein p53 | 2 | 2022 | 508 | 0.070 |
Why?
| Fathers | 1 | 2006 | 47 | 0.070 |
Why?
| Science | 1 | 2007 | 53 | 0.070 |
Why?
| False Positive Reactions | 1 | 2006 | 115 | 0.070 |
Why?
| Prognosis | 4 | 2018 | 3787 | 0.060 |
Why?
| Auditory Cortex | 2 | 1997 | 40 | 0.060 |
Why?
| Prevalence | 2 | 2017 | 2540 | 0.060 |
Why?
| Azithromycin | 1 | 2006 | 92 | 0.060 |
Why?
| Urethritis | 1 | 2005 | 3 | 0.060 |
Why?
| Length of Stay | 3 | 2015 | 1126 | 0.060 |
Why?
| Uterine Cervical Diseases | 1 | 2005 | 6 | 0.060 |
Why?
| Breast Neoplasms | 1 | 1998 | 2112 | 0.060 |
Why?
| Maternal Health Services | 1 | 2007 | 93 | 0.060 |
Why?
| Fatty Liver | 1 | 2008 | 230 | 0.060 |
Why?
| Self Efficacy | 2 | 2019 | 377 | 0.060 |
Why?
| Teaching | 1 | 2007 | 209 | 0.060 |
Why?
| Chronic Disease | 2 | 2024 | 1715 | 0.060 |
Why?
| Metabolic Syndrome | 1 | 2008 | 339 | 0.060 |
Why?
| Metformin | 1 | 2008 | 307 | 0.060 |
Why?
| Herb-Drug Interactions | 1 | 2023 | 4 | 0.060 |
Why?
| Texas | 1 | 2024 | 227 | 0.060 |
Why?
| Acanthosis Nigricans | 1 | 2003 | 6 | 0.060 |
Why?
| Biomarkers, Tumor | 2 | 2022 | 1170 | 0.060 |
Why?
| Hospitals, University | 2 | 2016 | 177 | 0.050 |
Why?
| Combined Modality Therapy | 2 | 2015 | 1213 | 0.050 |
Why?
| Diagnosis, Differential | 2 | 2008 | 1435 | 0.050 |
Why?
| Cytochrome P-450 CYP3A Inducers | 1 | 2023 | 5 | 0.050 |
Why?
| Urban Population | 2 | 2016 | 436 | 0.050 |
Why?
| Ovulation | 1 | 2023 | 40 | 0.050 |
Why?
| Program Evaluation | 2 | 2019 | 868 | 0.050 |
Why?
| Lung Neoplasms | 1 | 2016 | 2353 | 0.050 |
Why?
| Rifampin | 1 | 2023 | 82 | 0.050 |
Why?
| Diet | 2 | 2024 | 1205 | 0.050 |
Why?
| Longitudinal Studies | 3 | 2017 | 2668 | 0.050 |
Why?
| Episiotomy | 1 | 2022 | 2 | 0.050 |
Why?
| Anxiety | 2 | 2019 | 947 | 0.050 |
Why?
| Neoplasms | 1 | 2016 | 2426 | 0.050 |
Why?
| Pregnancy, Twin | 1 | 2021 | 17 | 0.050 |
Why?
| Menstrual Cycle | 1 | 2022 | 124 | 0.050 |
Why?
| Anti-Bacterial Agents | 2 | 2014 | 1701 | 0.050 |
Why?
| Pharmacogenomic Variants | 1 | 2021 | 35 | 0.050 |
Why?
| Alpha Rhythm | 1 | 2000 | 6 | 0.040 |
Why?
| Biomedical Research | 1 | 2007 | 654 | 0.040 |
Why?
| Reproduction | 1 | 2022 | 200 | 0.040 |
Why?
| Wrist | 1 | 2021 | 52 | 0.040 |
Why?
| Time-to-Pregnancy | 1 | 2020 | 5 | 0.040 |
Why?
| Clinical Trials, Phase I as Topic | 1 | 2020 | 50 | 0.040 |
Why?
| Analysis of Variance | 5 | 2005 | 1283 | 0.040 |
Why?
| Coitus | 2 | 2011 | 25 | 0.040 |
Why?
| Cytochrome P-450 CYP2C9 | 1 | 2019 | 20 | 0.040 |
Why?
| Mother-Child Relations | 1 | 2021 | 133 | 0.040 |
Why?
| Refractory Period, Electrophysiological | 1 | 1999 | 5 | 0.040 |
Why?
| Ethics, Medical | 1 | 2020 | 79 | 0.040 |
Why?
| Cytochrome P-450 CYP2C19 | 1 | 2019 | 23 | 0.040 |
Why?
| Needs Assessment | 2 | 2015 | 360 | 0.040 |
Why?
| Poverty | 2 | 2017 | 492 | 0.040 |
Why?
| Electroencephalography | 2 | 1999 | 387 | 0.040 |
Why?
| Cytoreduction Surgical Procedures | 1 | 2020 | 61 | 0.040 |
Why?
| Reproducibility of Results | 3 | 2023 | 3042 | 0.040 |
Why?
| Median Nerve | 1 | 1999 | 22 | 0.040 |
Why?
| Mutation | 2 | 2022 | 3671 | 0.040 |
Why?
| Tissue Donors | 1 | 2022 | 398 | 0.040 |
Why?
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2000 | 70 | 0.040 |
Why?
| Neural Inhibition | 1 | 2000 | 151 | 0.040 |
Why?
| Ethics, Institutional | 1 | 2019 | 4 | 0.040 |
Why?
| Visible Human Projects | 1 | 2019 | 2 | 0.040 |
Why?
| Genital Diseases, Female | 1 | 2019 | 27 | 0.040 |
Why?
| Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 33 | 0.040 |
Why?
| Reproductive Health Services | 1 | 2019 | 14 | 0.040 |
Why?
| Hypoglycemic Agents | 1 | 2008 | 1206 | 0.040 |
Why?
| Microsatellite Instability | 1 | 2019 | 35 | 0.040 |
Why?
| DNA Polymerase II | 1 | 2019 | 38 | 0.040 |
Why?
| Adjuvants, Immunologic | 1 | 2000 | 219 | 0.040 |
Why?
| Operative Time | 1 | 2019 | 120 | 0.040 |
Why?
| Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 81 | 0.040 |
Why?
| Testosterone | 1 | 2022 | 382 | 0.040 |
Why?
| Pituitary Gland | 1 | 1999 | 147 | 0.040 |
Why?
| Intention to Treat Analysis | 1 | 2018 | 72 | 0.040 |
Why?
| Biological Variation, Population | 1 | 2018 | 20 | 0.040 |
Why?
| Morning Sickness | 1 | 2018 | 3 | 0.040 |
Why?
| Memory | 2 | 1999 | 231 | 0.040 |
Why?
| Midazolam | 1 | 2018 | 49 | 0.040 |
Why?
| Electric Stimulation | 1 | 1999 | 266 | 0.040 |
Why?
| Thalamus | 1 | 1999 | 79 | 0.040 |
Why?
| Sensitivity and Specificity | 1 | 2023 | 1840 | 0.040 |
Why?
| Psychology, Adolescent | 2 | 2008 | 63 | 0.040 |
Why?
| Hippocampus | 2 | 2001 | 785 | 0.040 |
Why?
| DNA-Binding Proteins | 1 | 2005 | 1423 | 0.040 |
Why?
| Patient Care | 1 | 2019 | 109 | 0.040 |
Why?
| Carmustine | 1 | 1998 | 50 | 0.040 |
Why?
| PTEN Phosphohydrolase | 1 | 2019 | 148 | 0.040 |
Why?
| Fentanyl | 1 | 2018 | 78 | 0.040 |
Why?
| Frozen Sections | 1 | 2018 | 26 | 0.040 |
Why?
| Creatine | 1 | 1998 | 55 | 0.040 |
Why?
| Aspartic Acid | 1 | 1998 | 79 | 0.040 |
Why?
| Disease-Free Survival | 1 | 2019 | 657 | 0.040 |
Why?
| Memory, Short-Term | 1 | 2000 | 255 | 0.040 |
Why?
| Antineoplastic Agents | 2 | 2020 | 2038 | 0.040 |
Why?
| Legislation, Drug | 1 | 2018 | 81 | 0.040 |
Why?
| Hysterosalpingography | 1 | 2017 | 6 | 0.040 |
Why?
| Insurance Coverage | 1 | 2019 | 220 | 0.040 |
Why?
| Cyclophosphamide | 1 | 1998 | 232 | 0.040 |
Why?
| Neoadjuvant Therapy | 1 | 2020 | 383 | 0.030 |
Why?
| Sterilization, Tubal | 1 | 2017 | 13 | 0.030 |
Why?
| Transcription Factors | 1 | 2005 | 1634 | 0.030 |
Why?
| Survival Analysis | 1 | 2020 | 1282 | 0.030 |
Why?
| Health Surveys | 1 | 2019 | 485 | 0.030 |
Why?
| Survival Rate | 1 | 2021 | 1884 | 0.030 |
Why?
| Chemotherapy, Adjuvant | 1 | 1998 | 380 | 0.030 |
Why?
| Hospitals, Private | 1 | 2016 | 12 | 0.030 |
Why?
| Health Facility Size | 1 | 2016 | 11 | 0.030 |
Why?
| Cisplatin | 1 | 1998 | 292 | 0.030 |
Why?
| Pain Measurement | 1 | 2018 | 489 | 0.030 |
Why?
| Colony Count, Microbial | 1 | 2016 | 116 | 0.030 |
Why?
| AC133 Antigen | 1 | 2015 | 19 | 0.030 |
Why?
| Self Care | 1 | 2019 | 369 | 0.030 |
Why?
| Marriage | 1 | 2017 | 111 | 0.030 |
Why?
| Marijuana Abuse | 1 | 2019 | 230 | 0.030 |
Why?
| Radiotherapy | 1 | 2016 | 186 | 0.030 |
Why?
| Brain Injuries | 1 | 2001 | 468 | 0.030 |
Why?
| Medical Audit | 1 | 2016 | 78 | 0.030 |
Why?
| Hospitals, Teaching | 1 | 2016 | 112 | 0.030 |
Why?
| Patient Simulation | 1 | 2015 | 34 | 0.030 |
Why?
| Reaction Time | 4 | 2000 | 407 | 0.030 |
Why?
| Terminal Care | 1 | 2019 | 238 | 0.030 |
Why?
| Stem Cell Transplantation | 1 | 2016 | 167 | 0.030 |
Why?
| North America | 1 | 2016 | 289 | 0.030 |
Why?
| Ileus | 1 | 2015 | 12 | 0.030 |
Why?
| Indians, North American | 1 | 2021 | 603 | 0.030 |
Why?
| Cell Count | 1 | 2015 | 316 | 0.030 |
Why?
| Income | 1 | 2016 | 191 | 0.030 |
Why?
| Chi-Square Distribution | 2 | 2006 | 513 | 0.030 |
Why?
| Urinary Retention | 1 | 2015 | 22 | 0.030 |
Why?
| Competitive Behavior | 1 | 2015 | 41 | 0.030 |
Why?
| Female Urogenital Diseases | 1 | 2014 | 5 | 0.030 |
Why?
| Elective Surgical Procedures | 1 | 2016 | 164 | 0.030 |
Why?
| Adolescent Nutritional Physiological Phenomena | 1 | 2014 | 26 | 0.030 |
Why?
| Memory Disorders | 1 | 1996 | 156 | 0.030 |
Why?
| Natural Family Planning Methods | 1 | 2014 | 3 | 0.030 |
Why?
| Laparoscopy | 1 | 2019 | 452 | 0.030 |
Why?
| Morbidity | 1 | 2015 | 301 | 0.030 |
Why?
| Receptors, Androgen | 1 | 2015 | 141 | 0.030 |
Why?
| Intraoperative Complications | 1 | 2015 | 133 | 0.030 |
Why?
| Delivery of Health Care, Integrated | 1 | 2017 | 248 | 0.030 |
Why?
| Peritoneal Cavity | 1 | 2014 | 30 | 0.030 |
Why?
| Homosexuality, Male | 1 | 1995 | 171 | 0.030 |
Why?
| Blood Volume | 1 | 2014 | 60 | 0.030 |
Why?
| Severity of Illness Index | 2 | 2015 | 2767 | 0.030 |
Why?
| Hemostatics | 1 | 2014 | 47 | 0.030 |
Why?
| Vagina | 1 | 2016 | 173 | 0.030 |
Why?
| Pelvis | 1 | 2015 | 102 | 0.030 |
Why?
| Personnel Selection | 1 | 2015 | 72 | 0.030 |
Why?
| Surgical Procedures, Operative | 1 | 2016 | 249 | 0.030 |
Why?
| Acoustic Stimulation | 3 | 2000 | 321 | 0.030 |
Why?
| Educational Measurement | 1 | 2016 | 259 | 0.030 |
Why?
| Administration, Intravaginal | 1 | 2013 | 17 | 0.030 |
Why?
| Insurance, Health | 1 | 2016 | 269 | 0.030 |
Why?
| Cesarean Section | 1 | 2015 | 180 | 0.030 |
Why?
| Disease Progression | 2 | 2017 | 2603 | 0.030 |
Why?
| Drainage | 1 | 2014 | 162 | 0.030 |
Why?
| Receptors, Progesterone | 1 | 2015 | 342 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2017 | 1504 | 0.030 |
Why?
| Child Development | 1 | 1998 | 451 | 0.030 |
Why?
| Dose-Response Relationship, Drug | 1 | 1998 | 1968 | 0.030 |
Why?
| Drug Administration Schedule | 1 | 2015 | 760 | 0.030 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2021 | 2070 | 0.030 |
Why?
| Insulin | 1 | 2003 | 2311 | 0.030 |
Why?
| Receptors, Estrogen | 1 | 2015 | 423 | 0.030 |
Why?
| Alcoholism | 1 | 1999 | 759 | 0.030 |
Why?
| Patient Readmission | 1 | 2018 | 674 | 0.030 |
Why?
| Membrane Proteins | 1 | 2019 | 1100 | 0.030 |
Why?
| Multiple Sclerosis | 1 | 1998 | 427 | 0.020 |
Why?
| Hematopoietic Stem Cell Transplantation | 1 | 1998 | 576 | 0.020 |
Why?
| Text Messaging | 1 | 2014 | 146 | 0.020 |
Why?
| Health Care Surveys | 1 | 2014 | 560 | 0.020 |
Why?
| Perception | 1 | 2015 | 336 | 0.020 |
Why?
| Escherichia coli | 1 | 2016 | 782 | 0.020 |
Why?
| Biomarkers | 1 | 2023 | 3874 | 0.020 |
Why?
| Specialty Boards | 1 | 2011 | 33 | 0.020 |
Why?
| Registries | 1 | 2019 | 1916 | 0.020 |
Why?
| Phenotype | 1 | 1999 | 3059 | 0.020 |
Why?
| Faculty | 1 | 2011 | 132 | 0.020 |
Why?
| Medicaid | 1 | 2014 | 445 | 0.020 |
Why?
| Interferon beta-1a | 2 | 2000 | 12 | 0.020 |
Why?
| Physicians | 1 | 2018 | 846 | 0.020 |
Why?
| New York City | 1 | 2009 | 81 | 0.020 |
Why?
| Urban Health Services | 1 | 2009 | 61 | 0.020 |
Why?
| Students | 1 | 2014 | 576 | 0.020 |
Why?
| Gravidity | 1 | 2008 | 7 | 0.020 |
Why?
| Injections, Intramuscular | 2 | 2000 | 127 | 0.020 |
Why?
| Interviews as Topic | 1 | 2011 | 696 | 0.020 |
Why?
| Patient Discharge | 1 | 2015 | 858 | 0.020 |
Why?
| Cell Line, Tumor | 1 | 2015 | 3100 | 0.020 |
Why?
| Quality of Life | 1 | 2020 | 2706 | 0.020 |
Why?
| Southwestern United States | 1 | 2008 | 91 | 0.020 |
Why?
| Cross-Cultural Comparison | 1 | 2008 | 80 | 0.020 |
Why?
| Aging | 1 | 1998 | 1767 | 0.020 |
Why?
| Urine | 1 | 2007 | 56 | 0.020 |
Why?
| Cholesterol, HDL | 1 | 2008 | 203 | 0.020 |
Why?
| Puberty | 1 | 2008 | 143 | 0.020 |
Why?
| Social Perception | 1 | 2008 | 103 | 0.020 |
Why?
| Medical Indigency | 1 | 2006 | 11 | 0.020 |
Why?
| Urinalysis | 1 | 2007 | 70 | 0.020 |
Why?
| Forecasting | 1 | 2008 | 363 | 0.020 |
Why?
| Child, Preschool | 1 | 2021 | 10457 | 0.020 |
Why?
| Apoptosis | 1 | 2015 | 2481 | 0.020 |
Why?
| Education | 1 | 2007 | 98 | 0.020 |
Why?
| National Institutes of Health (U.S.) | 1 | 2007 | 122 | 0.020 |
Why?
| Hospitalization | 1 | 2016 | 2080 | 0.020 |
Why?
| Health Services Needs and Demand | 1 | 2008 | 258 | 0.020 |
Why?
| Social Environment | 1 | 2008 | 290 | 0.020 |
Why?
| Research Support as Topic | 1 | 2007 | 113 | 0.020 |
Why?
| Triglycerides | 1 | 2008 | 519 | 0.020 |
Why?
| Tomography, X-Ray Computed | 1 | 2014 | 2530 | 0.010 |
Why?
| Universities | 1 | 2007 | 404 | 0.010 |
Why?
| Attention | 2 | 1999 | 434 | 0.010 |
Why?
| Reagent Kits, Diagnostic | 1 | 2004 | 43 | 0.010 |
Why?
| Sex Characteristics | 2 | 1999 | 722 | 0.010 |
Why?
| Self Concept | 1 | 2005 | 236 | 0.010 |
Why?
| Data Interpretation, Statistical | 1 | 2005 | 336 | 0.010 |
Why?
| Research | 1 | 2005 | 413 | 0.010 |
Why?
| Proportional Hazards Models | 1 | 2005 | 1221 | 0.010 |
Why?
| Image Processing, Computer-Assisted | 2 | 1997 | 739 | 0.010 |
Why?
| Blood Pressure | 1 | 2008 | 1743 | 0.010 |
Why?
| Electromagnetic Fields | 1 | 1999 | 23 | 0.010 |
Why?
| Schizophrenic Psychology | 1 | 1999 | 93 | 0.010 |
Why?
| Wechsler Scales | 1 | 1998 | 53 | 0.010 |
Why?
| Blood Glucose | 1 | 2008 | 2086 | 0.010 |
Why?
| Cognition | 1 | 2005 | 1093 | 0.010 |
Why?
| Gadolinium | 1 | 1998 | 77 | 0.010 |
Why?
| Sound Localization | 1 | 1998 | 69 | 0.010 |
Why?
| Image Interpretation, Computer-Assisted | 1 | 1999 | 253 | 0.010 |
Why?
| Adrenal Cortex Hormones | 1 | 1999 | 525 | 0.010 |
Why?
| Least-Squares Analysis | 1 | 1995 | 72 | 0.010 |
Why?
| Confidence Intervals | 1 | 1996 | 318 | 0.010 |
Why?
| Verbal Behavior | 1 | 1995 | 47 | 0.010 |
Why?
| Space Perception | 1 | 1995 | 72 | 0.010 |
Why?
| Cognition Disorders | 1 | 1999 | 496 | 0.010 |
Why?
| Recurrence | 1 | 1998 | 1013 | 0.010 |
Why?
| Software | 1 | 1999 | 611 | 0.010 |
Why?
|
|
Sheeder's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|